Management of dyskinesia in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience

被引：0
|
作者：
Pagonabarraga, J. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Arbe, E. [5 ]
Rocha, J. [5 ]
Soares-Da-Silva, P. [6 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Unit Movement Disorders, Neurol, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Parkinson Dis & Movement Disorder Unit, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[6] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3069
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] Dyskinesia management in COMT-naive patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience
    Pagonabarraga, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Arbe, E.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S103 - S103
  • [2] Dopaminergic adverse-events in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience
    Chaudhuri, K. Ray
    Sauerbier, A.
    Ferreira, J.
    Stocchi, F.
    Arbe, E.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 247 - 247
  • [3] Occurrence of dopaminergic adverse-events in COMT-naive patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience
    Chaudhuri, K. Ray
    Sauerbier, A.
    Ferreira, J.
    Stocchi, F.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S135 - S135
  • [4] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: The BIPARK-I double-blind experience
    Kulisevsky, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S106 - S106
  • [5] Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials
    Hauser, R.
    Rascol, O.
    Poewe, W.
    Ferreira, J.
    Lees, A.
    Klepitskaya, O.
    Liang, G.
    Santos, A.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [6] Opicapone as a levodopa sparing agent: pooled analysis of BIPARK-I and II double-blind trials
    Hauser, R.
    Rascol, O.
    Poewe, W.
    Ferreira, J.
    Lees, A.
    Klepitskaya, O.
    Liang, G.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S46 - S46
  • [7] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: NMSS analysis from the BIPARK-I double-blind experience
    Antonini, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S135 - S136
  • [8] Results from the BIPARK-I double-blind experience on the efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations.
    Kulisevsky, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 650 - 650
  • [9] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Responder analyses from the BIPARK-I double-blind experience
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S103 - S104
  • [10] Efficacy responders to opicapone among Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 155 - 155
12345